ADVERTISEMENT

Guidelines for the management of cancer-related hypercalcaemia

Deepa Koli   |   Clinical Summary   |   10 January 2023
ADVERTISEMENT

Hypercalcaemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer and is associated with a high degree of morbidity and mortality. It affects an estimated 2%-30% of patients and most frequently occurs in patients with breast, lung, and renal cancer, as well as multiple myeloma.

The...

          

February Challenge

Ends in 6d 16h
left
right

Topic Challenges

left
right